NEW YORK, Sept. 24, 2013 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of BioScrip, Inc. ("BioScrip" or the "Company") (NASDAQ: BIOS), concerning whether the board has breached its fiduciary duties to......
More...







